COMPANY
KayoThera
NIH awards 2
- NIH award 1R43DK136420-01 FY2023: $337,609 awarded for that fiscal year; activity R43 (SBIR); PI ESPOSITO, MARK; recipient as written: KAYOTHERA INC., PRINCETON, NJ. Development of first-in-class antagonists of the r source ↗
- NIH award 1R43CA278127-01 FY2023: $398,040 awarded for that fiscal year; activity R43 (SBIR); PI ESPOSITO, MARK; recipient as written: KAYOTHERA INC., PRINCETON, NJ. Development of first-in-class antagonists of the r source ↗